View in EDS HTML Full Text PDF Full Text

Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.

Saved in:
Bibliographic Details
Title: Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.
Authors: Alijanzadeh D; Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Moghim S; Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran., Zarand P; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Akbarzadeh MA; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zarinfar Y; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Khaheshi I; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. isa_khaheshi@yahoo.com.
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2025 Dec; Vol. 39 (6), pp. 1567-1584. Date of Electronic Publication: 2024 Dec 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39656365
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alijanzadeh+D%22">Alijanzadeh D</searchLink>; Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Moghim+S%22">Moghim S</searchLink>; Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.<br /><searchLink fieldCode="AU" term="%22Zarand+P%22">Zarand P</searchLink>; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Akbarzadeh+MA%22">Akbarzadeh MA</searchLink>; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Zarinfar+Y%22">Zarinfar Y</searchLink>; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Khaheshi+I%22">Khaheshi I</searchLink>; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. isa_khaheshi@yahoo.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228712220%22">Cardiovascular drugs and therapy</searchLink> [Cardiovasc Drugs Ther] 2025 Dec; Vol. 39 (6), pp. 1567-1584. <i>Date of Electronic Publication: </i>2024 Dec 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+For+The+International+Society+For+Cardiovascular+Pharmacotherapy%22">Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8712220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209203206%22">09203206 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Drugs Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39656365
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10557-024-07652-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1567
    Titles:
      – TitleFull: Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alijanzadeh D
      – PersonEntity:
          Name:
            NameFull: Moghim S
      – PersonEntity:
          Name:
            NameFull: Zarand P
      – PersonEntity:
          Name:
            NameFull: Akbarzadeh MA
      – PersonEntity:
          Name:
            NameFull: Zarinfar Y
      – PersonEntity:
          Name:
            NameFull: Khaheshi I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7241
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cardiovascular drugs and therapy
              Type: main
ResultId 1